nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—SLC12A1—appendage—sarcoma	0.0264	0.0603	CbGeAlD
Bumetanide—SLC12A4—mammary gland—sarcoma	0.0222	0.0507	CbGeAlD
Bumetanide—Hypochloraemia—Epirubicin—sarcoma	0.0204	0.0363	CcSEcCtD
Bumetanide—Hypochloraemia—Doxorubicin—sarcoma	0.0188	0.0336	CcSEcCtD
Bumetanide—Amylase increased—Thiotepa—sarcoma	0.0164	0.0293	CcSEcCtD
Bumetanide—SLC12A2—mammary gland—sarcoma	0.0153	0.035	CbGeAlD
Bumetanide—SLC12A4—embryo—sarcoma	0.0152	0.0346	CbGeAlD
Bumetanide—PTGS2—periosteum—sarcoma	0.0143	0.0325	CbGeAlD
Bumetanide—Azotaemia—Vincristine—sarcoma	0.013	0.0232	CcSEcCtD
Bumetanide—Encephalopathy—Thiotepa—sarcoma	0.0122	0.0217	CcSEcCtD
Bumetanide—PTGS2—leg—sarcoma	0.0114	0.0259	CbGeAlD
Bumetanide—CFTR—seminal vesicle—sarcoma	0.0112	0.0255	CbGeAlD
Bumetanide—Serum creatinine increased—Mitoxantrone—sarcoma	0.011	0.0196	CcSEcCtD
Bumetanide—CFTR—hematopoietic system—sarcoma	0.0106	0.0243	CbGeAlD
Bumetanide—SLC12A4—uterus—sarcoma	0.0102	0.0233	CbGeAlD
Bumetanide—PTGS2—hindlimb—sarcoma	0.0101	0.0231	CbGeAlD
Bumetanide—CA5B—mammary gland—sarcoma	0.01	0.0229	CbGeAlD
Bumetanide—PTGS2—cartilage tissue—sarcoma	0.00999	0.0228	CbGeAlD
Bumetanide—SLC12A2—hematopoietic system—sarcoma	0.00935	0.0213	CbGeAlD
Bumetanide—SLC10A1—seminal vesicle—sarcoma	0.00929	0.0212	CbGeAlD
Bumetanide—CA14—seminal vesicle—sarcoma	0.00918	0.0209	CbGeAlD
Bumetanide—SLC12A5—testis—sarcoma	0.00894	0.0204	CbGeAlD
Bumetanide—PTGS2—appendage—sarcoma	0.0087	0.0199	CbGeAlD
Bumetanide—Hyperuricaemia—Thiotepa—sarcoma	0.00844	0.015	CcSEcCtD
Bumetanide—Hearing impaired—Thiotepa—sarcoma	0.00822	0.0146	CcSEcCtD
Bumetanide—CA5A—liver—sarcoma	0.00816	0.0186	CbGeAlD
Bumetanide—Blood uric acid increased—Thiotepa—sarcoma	0.00797	0.0142	CcSEcCtD
Bumetanide—SLC12A1—hematopoietic system—sarcoma	0.00784	0.0179	CbGeAlD
Bumetanide—Hyperuricaemia—Vincristine—sarcoma	0.00748	0.0133	CcSEcCtD
Bumetanide—SLC12A4—testis—sarcoma	0.00742	0.0169	CbGeAlD
Bumetanide—Hyperuricaemia—Mitoxantrone—sarcoma	0.00728	0.013	CcSEcCtD
Bumetanide—SLC12A2—cardiac atrium—sarcoma	0.0071	0.0162	CbGeAlD
Bumetanide—Blood uric acid increased—Vincristine—sarcoma	0.00707	0.0126	CcSEcCtD
Bumetanide—Musculoskeletal pain—Vincristine—sarcoma	0.00702	0.0125	CcSEcCtD
Bumetanide—SLC12A4—liver—sarcoma	0.00702	0.016	CbGeAlD
Bumetanide—Blood uric acid increased—Mitoxantrone—sarcoma	0.00688	0.0123	CcSEcCtD
Bumetanide—CA14—cardiac atrium—sarcoma	0.00663	0.0151	CbGeAlD
Bumetanide—CA12—connective tissue—sarcoma	0.00655	0.0149	CbGeAlD
Bumetanide—SLC12A2—tendon—sarcoma	0.00619	0.0141	CbGeAlD
Bumetanide—CA5B—hematopoietic system—sarcoma	0.00611	0.0139	CbGeAlD
Bumetanide—CA9—tendon—sarcoma	0.00609	0.0139	CbGeAlD
Bumetanide—Hyperuricaemia—Etoposide—sarcoma	0.00606	0.0108	CcSEcCtD
Bumetanide—SLC12A2—bone marrow—sarcoma	0.00599	0.0137	CbGeAlD
Bumetanide—CFTR—testis—sarcoma	0.00583	0.0133	CbGeAlD
Bumetanide—CA14—tendon—sarcoma	0.00578	0.0132	CbGeAlD
Bumetanide—Polyuria—Vincristine—sarcoma	0.00574	0.0102	CcSEcCtD
Bumetanide—Blood uric acid increased—Etoposide—sarcoma	0.00572	0.0102	CcSEcCtD
Bumetanide—CFTR—liver—sarcoma	0.00551	0.0126	CbGeAlD
Bumetanide—SLC12A4—lymph node—sarcoma	0.00538	0.0123	CbGeAlD
Bumetanide—Blood creatinine increased—Thiotepa—sarcoma	0.00532	0.00948	CcSEcCtD
Bumetanide—Dehydration—Thiotepa—sarcoma	0.00528	0.00941	CcSEcCtD
Bumetanide—PTGS2—endothelium—sarcoma	0.00525	0.012	CbGeAlD
Bumetanide—Serum creatinine increased—Epirubicin—sarcoma	0.00512	0.00912	CcSEcCtD
Bumetanide—SLC12A2—testis—sarcoma	0.00512	0.0117	CbGeAlD
Bumetanide—Toxic epidermal necrolysis—Dactinomycin—sarcoma	0.00508	0.00904	CcSEcCtD
Bumetanide—Hyponatraemia—Vincristine—sarcoma	0.00506	0.00901	CcSEcCtD
Bumetanide—CA9—testis—sarcoma	0.00504	0.0115	CbGeAlD
Bumetanide—Hyponatraemia—Mitoxantrone—sarcoma	0.00493	0.00877	CcSEcCtD
Bumetanide—SLC12A2—liver—sarcoma	0.00484	0.011	CbGeAlD
Bumetanide—SLC10A1—testis—sarcoma	0.00484	0.011	CbGeAlD
Bumetanide—SLCO1A2—hematopoietic system—sarcoma	0.00476	0.0109	CbGeAlD
Bumetanide—Serum creatinine increased—Doxorubicin—sarcoma	0.00474	0.00844	CcSEcCtD
Bumetanide—Dehydration—Vincristine—sarcoma	0.00468	0.00834	CcSEcCtD
Bumetanide—CA5B—cardiac atrium—sarcoma	0.00464	0.0106	CbGeAlD
Bumetanide—Blood creatinine increased—Mitoxantrone—sarcoma	0.0046	0.00818	CcSEcCtD
Bumetanide—Hyperventilation—Epirubicin—sarcoma	0.00458	0.00815	CcSEcCtD
Bumetanide—SLC10A1—liver—sarcoma	0.00457	0.0104	CbGeAlD
Bumetanide—Dehydration—Mitoxantrone—sarcoma	0.00456	0.00812	CcSEcCtD
Bumetanide—SLC22A8—hematopoietic system—sarcoma	0.00455	0.0104	CbGeAlD
Bumetanide—CA14—liver—sarcoma	0.00452	0.0103	CbGeAlD
Bumetanide—Hypokalaemia—Mitoxantrone—sarcoma	0.00446	0.00795	CcSEcCtD
Bumetanide—CA4—seminal vesicle—sarcoma	0.00443	0.0101	CbGeAlD
Bumetanide—Hyperglycaemia—Thiotepa—sarcoma	0.00443	0.00789	CcSEcCtD
Bumetanide—SLC22A7—testis—sarcoma	0.00431	0.00984	CbGeAlD
Bumetanide—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00431	0.00767	CcSEcCtD
Bumetanide—Renal failure—Thiotepa—sarcoma	0.0043	0.00766	CcSEcCtD
Bumetanide—SLC12A1—testis—sarcoma	0.00429	0.00979	CbGeAlD
Bumetanide—Hyperventilation—Doxorubicin—sarcoma	0.00424	0.00754	CcSEcCtD
Bumetanide—SLC22A11—liver—sarcoma	0.00418	0.00953	CbGeAlD
Bumetanide—SLC22A7—liver—sarcoma	0.00408	0.0093	CbGeAlD
Bumetanide—CA5B—tendon—sarcoma	0.00404	0.00922	CbGeAlD
Bumetanide—Glycosuria—Epirubicin—sarcoma	0.00389	0.00693	CcSEcCtD
Bumetanide—Hyperglycaemia—Mitoxantrone—sarcoma	0.00382	0.00681	CcSEcCtD
Bumetanide—Blood disorder—Epirubicin—sarcoma	0.00377	0.00672	CcSEcCtD
Bumetanide—Liver injury—Epirubicin—sarcoma	0.00374	0.00667	CcSEcCtD
Bumetanide—Sweating—Vincristine—sarcoma	0.00372	0.00663	CcSEcCtD
Bumetanide—Renal failure—Mitoxantrone—sarcoma	0.00372	0.00662	CcSEcCtD
Bumetanide—SLC12A2—lymph node—sarcoma	0.00371	0.00847	CbGeAlD
Bumetanide—Erythema multiforme—Dactinomycin—sarcoma	0.00369	0.00657	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Etoposide—sarcoma	0.00367	0.00654	CcSEcCtD
Bumetanide—Cramp muscle—Etoposide—sarcoma	0.00367	0.00654	CcSEcCtD
Bumetanide—Sweating—Mitoxantrone—sarcoma	0.00362	0.00645	CcSEcCtD
Bumetanide—Glycosuria—Doxorubicin—sarcoma	0.0036	0.00641	CcSEcCtD
Bumetanide—Blood disorder—Doxorubicin—sarcoma	0.00349	0.00622	CcSEcCtD
Bumetanide—Liver injury—Doxorubicin—sarcoma	0.00346	0.00617	CcSEcCtD
Bumetanide—Hyperuricaemia—Epirubicin—sarcoma	0.0034	0.00605	CcSEcCtD
Bumetanide—CA5B—testis—sarcoma	0.00335	0.00763	CbGeAlD
Bumetanide—Blood uric acid increased—Epirubicin—sarcoma	0.00321	0.00571	CcSEcCtD
Bumetanide—CA4—cardiac atrium—sarcoma	0.0032	0.0073	CbGeAlD
Bumetanide—Musculoskeletal pain—Epirubicin—sarcoma	0.00319	0.00568	CcSEcCtD
Bumetanide—Hepatocellular injury—Epirubicin—sarcoma	0.00315	0.00561	CcSEcCtD
Bumetanide—Hyperuricaemia—Doxorubicin—sarcoma	0.00314	0.0056	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00312	0.00555	CcSEcCtD
Bumetanide—Renal failure—Etoposide—sarcoma	0.00309	0.0055	CcSEcCtD
Bumetanide—Leukopenia—Thiotepa—sarcoma	0.00306	0.00545	CcSEcCtD
Bumetanide—Leukopenia—Dactinomycin—sarcoma	0.00304	0.00541	CcSEcCtD
Bumetanide—PTGS2—myometrium—sarcoma	0.003	0.00685	CbGeAlD
Bumetanide—Blood uric acid increased—Doxorubicin—sarcoma	0.00297	0.00529	CcSEcCtD
Bumetanide—Musculoskeletal pain—Doxorubicin—sarcoma	0.00295	0.00525	CcSEcCtD
Bumetanide—Hepatocellular injury—Doxorubicin—sarcoma	0.00292	0.00519	CcSEcCtD
Bumetanide—Arthralgia—Thiotepa—sarcoma	0.00291	0.00519	CcSEcCtD
Bumetanide—PTGS2—embryo—sarcoma	0.00289	0.00659	CbGeAlD
Bumetanide—CA4—tendon—sarcoma	0.00279	0.00636	CbGeAlD
Bumetanide—Thrombocytopenia—Thiotepa—sarcoma	0.00273	0.00487	CcSEcCtD
Bumetanide—Vertigo—Vincristine—sarcoma	0.00273	0.00485	CcSEcCtD
Bumetanide—Leukopenia—Vincristine—sarcoma	0.00272	0.00484	CcSEcCtD
Bumetanide—PTGS2—seminal vesicle—sarcoma	0.00271	0.00619	CbGeAlD
Bumetanide—Thrombocytopenia—Dactinomycin—sarcoma	0.00271	0.00483	CcSEcCtD
Bumetanide—CA4—bone marrow—sarcoma	0.0027	0.00616	CbGeAlD
Bumetanide—Erythema multiforme—Etoposide—sarcoma	0.00267	0.00475	CcSEcCtD
Bumetanide—Leukopenia—Mitoxantrone—sarcoma	0.00264	0.00471	CcSEcCtD
Bumetanide—SLCO1A2—testis—sarcoma	0.00261	0.00595	CbGeAlD
Bumetanide—PTGS2—hematopoietic system—sarcoma	0.00258	0.00588	CbGeAlD
Bumetanide—Chest pain—Mitoxantrone—sarcoma	0.00251	0.00448	CcSEcCtD
Bumetanide—Arthralgia—Mitoxantrone—sarcoma	0.00251	0.00448	CcSEcCtD
Bumetanide—PTGS2—connective tissue—sarcoma	0.00248	0.00567	CbGeAlD
Bumetanide—SLCO1A2—liver—sarcoma	0.00247	0.00563	CbGeAlD
Bumetanide—CA5B—lymph node—sarcoma	0.00243	0.00553	CbGeAlD
Bumetanide—Thrombocytopenia—Vincristine—sarcoma	0.00242	0.00432	CcSEcCtD
Bumetanide—Fatigue—Thiotepa—sarcoma	0.00241	0.00429	CcSEcCtD
Bumetanide—Hyperhidrosis—Vincristine—sarcoma	0.00239	0.00426	CcSEcCtD
Bumetanide—Fatigue—Dactinomycin—sarcoma	0.00239	0.00425	CcSEcCtD
Bumetanide—Muscle spasms—Etoposide—sarcoma	0.00236	0.00421	CcSEcCtD
Bumetanide—Thrombocytopenia—Mitoxantrone—sarcoma	0.00236	0.0042	CcSEcCtD
Bumetanide—Hyperhidrosis—Mitoxantrone—sarcoma	0.00233	0.00415	CcSEcCtD
Bumetanide—Hypotension—Vincristine—sarcoma	0.00231	0.00412	CcSEcCtD
Bumetanide—CA4—testis—sarcoma	0.00231	0.00527	CbGeAlD
Bumetanide—Hyponatraemia—Epirubicin—sarcoma	0.0023	0.00409	CcSEcCtD
Bumetanide—Gastrointestinal pain—Thiotepa—sarcoma	0.00228	0.00407	CcSEcCtD
Bumetanide—PTGS2—smooth muscle tissue—sarcoma	0.00227	0.00518	CbGeAlD
Bumetanide—Gastrointestinal pain—Dactinomycin—sarcoma	0.00227	0.00403	CcSEcCtD
Bumetanide—Hypotension—Mitoxantrone—sarcoma	0.00225	0.00401	CcSEcCtD
Bumetanide—PTGS2—skin of body—sarcoma	0.00224	0.00512	CbGeAlD
Bumetanide—Urticaria—Thiotepa—sarcoma	0.00222	0.00395	CcSEcCtD
Bumetanide—Vertigo—Etoposide—sarcoma	0.00221	0.00393	CcSEcCtD
Bumetanide—Abdominal pain—Thiotepa—sarcoma	0.00221	0.00393	CcSEcCtD
Bumetanide—Leukopenia—Etoposide—sarcoma	0.0022	0.00392	CcSEcCtD
Bumetanide—Abdominal pain—Dactinomycin—sarcoma	0.00219	0.0039	CcSEcCtD
Bumetanide—Blood creatinine increased—Epirubicin—sarcoma	0.00214	0.00382	CcSEcCtD
Bumetanide—Fatigue—Vincristine—sarcoma	0.00213	0.0038	CcSEcCtD
Bumetanide—Dehydration—Epirubicin—sarcoma	0.00213	0.00379	CcSEcCtD
Bumetanide—Hyponatraemia—Doxorubicin—sarcoma	0.00212	0.00378	CcSEcCtD
Bumetanide—Chest pain—Etoposide—sarcoma	0.00209	0.00373	CcSEcCtD
Bumetanide—Hypokalaemia—Epirubicin—sarcoma	0.00208	0.00371	CcSEcCtD
Bumetanide—Fatigue—Mitoxantrone—sarcoma	0.00208	0.0037	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00206	0.00367	CcSEcCtD
Bumetanide—Gastrointestinal pain—Vincristine—sarcoma	0.00202	0.0036	CcSEcCtD
Bumetanide—Asthenia—Thiotepa—sarcoma	0.002	0.00357	CcSEcCtD
Bumetanide—Asthenia—Dactinomycin—sarcoma	0.00199	0.00354	CcSEcCtD
Bumetanide—Blood creatinine increased—Doxorubicin—sarcoma	0.00198	0.00353	CcSEcCtD
Bumetanide—Pruritus—Thiotepa—sarcoma	0.00198	0.00352	CcSEcCtD
Bumetanide—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00197	0.00351	CcSEcCtD
Bumetanide—Dehydration—Doxorubicin—sarcoma	0.00197	0.0035	CcSEcCtD
Bumetanide—Thrombocytopenia—Etoposide—sarcoma	0.00196	0.0035	CcSEcCtD
Bumetanide—Abdominal pain—Vincristine—sarcoma	0.00196	0.00348	CcSEcCtD
Bumetanide—PTGS2—uterus—sarcoma	0.00195	0.00445	CbGeAlD
Bumetanide—Hyperhidrosis—Etoposide—sarcoma	0.00194	0.00345	CcSEcCtD
Bumetanide—Pancreatitis—Epirubicin—sarcoma	0.00194	0.00345	CcSEcCtD
Bumetanide—Hypokalaemia—Doxorubicin—sarcoma	0.00193	0.00343	CcSEcCtD
Bumetanide—Urticaria—Mitoxantrone—sarcoma	0.00192	0.00341	CcSEcCtD
Bumetanide—Diarrhoea—Thiotepa—sarcoma	0.00191	0.0034	CcSEcCtD
Bumetanide—Abdominal pain—Mitoxantrone—sarcoma	0.00191	0.00339	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00191	0.00339	CcSEcCtD
Bumetanide—Diarrhoea—Dactinomycin—sarcoma	0.0019	0.00338	CcSEcCtD
Bumetanide—Hypotension—Etoposide—sarcoma	0.00187	0.00334	CcSEcCtD
Bumetanide—Dizziness—Thiotepa—sarcoma	0.00185	0.00329	CcSEcCtD
Bumetanide—PTGS2—lymphoid tissue—sarcoma	0.00182	0.00414	CbGeAlD
Bumetanide—Pancreatitis—Doxorubicin—sarcoma	0.00179	0.00319	CcSEcCtD
Bumetanide—Hyperglycaemia—Epirubicin—sarcoma	0.00178	0.00318	CcSEcCtD
Bumetanide—Asthenia—Vincristine—sarcoma	0.00178	0.00316	CcSEcCtD
Bumetanide—Vomiting—Thiotepa—sarcoma	0.00178	0.00316	CcSEcCtD
Bumetanide—Vomiting—Dactinomycin—sarcoma	0.00176	0.00314	CcSEcCtD
Bumetanide—Rash—Thiotepa—sarcoma	0.00176	0.00313	CcSEcCtD
Bumetanide—Dermatitis—Thiotepa—sarcoma	0.00176	0.00313	CcSEcCtD
Bumetanide—Headache—Thiotepa—sarcoma	0.00175	0.00311	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00175	0.00311	CcSEcCtD
Bumetanide—Rash—Dactinomycin—sarcoma	0.00175	0.00311	CcSEcCtD
Bumetanide—Renal failure—Epirubicin—sarcoma	0.00173	0.00309	CcSEcCtD
Bumetanide—Asthenia—Mitoxantrone—sarcoma	0.00173	0.00308	CcSEcCtD
Bumetanide—Fatigue—Etoposide—sarcoma	0.00173	0.00308	CcSEcCtD
Bumetanide—PTGS2—tendon—sarcoma	0.00171	0.00389	CbGeAlD
Bumetanide—Diarrhoea—Vincristine—sarcoma	0.00169	0.00302	CcSEcCtD
Bumetanide—Sweating—Epirubicin—sarcoma	0.00169	0.00301	CcSEcCtD
Bumetanide—CA4—lymph node—sarcoma	0.00167	0.00382	CbGeAlD
Bumetanide—Nausea—Thiotepa—sarcoma	0.00166	0.00295	CcSEcCtD
Bumetanide—PTGS2—bone marrow—sarcoma	0.00165	0.00377	CbGeAlD
Bumetanide—Hyperglycaemia—Doxorubicin—sarcoma	0.00165	0.00294	CcSEcCtD
Bumetanide—Diarrhoea—Mitoxantrone—sarcoma	0.00165	0.00294	CcSEcCtD
Bumetanide—Nausea—Dactinomycin—sarcoma	0.00165	0.00293	CcSEcCtD
Bumetanide—Gastrointestinal pain—Etoposide—sarcoma	0.00164	0.00292	CcSEcCtD
Bumetanide—Dizziness—Vincristine—sarcoma	0.00164	0.00292	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00162	0.00288	CcSEcCtD
Bumetanide—Renal failure—Doxorubicin—sarcoma	0.0016	0.00285	CcSEcCtD
Bumetanide—Urticaria—Etoposide—sarcoma	0.00159	0.00284	CcSEcCtD
Bumetanide—Abdominal pain—Etoposide—sarcoma	0.00159	0.00282	CcSEcCtD
Bumetanide—Vomiting—Vincristine—sarcoma	0.00157	0.0028	CcSEcCtD
Bumetanide—Sweating—Doxorubicin—sarcoma	0.00156	0.00278	CcSEcCtD
Bumetanide—Rash—Vincristine—sarcoma	0.00156	0.00278	CcSEcCtD
Bumetanide—Dermatitis—Vincristine—sarcoma	0.00156	0.00278	CcSEcCtD
Bumetanide—Headache—Vincristine—sarcoma	0.00155	0.00276	CcSEcCtD
Bumetanide—Vomiting—Mitoxantrone—sarcoma	0.00153	0.00273	CcSEcCtD
Bumetanide—Rash—Mitoxantrone—sarcoma	0.00152	0.00271	CcSEcCtD
Bumetanide—Dermatitis—Mitoxantrone—sarcoma	0.00152	0.0027	CcSEcCtD
Bumetanide—Headache—Mitoxantrone—sarcoma	0.00151	0.00269	CcSEcCtD
Bumetanide—Erythema multiforme—Epirubicin—sarcoma	0.0015	0.00266	CcSEcCtD
Bumetanide—Nausea—Vincristine—sarcoma	0.00147	0.00262	CcSEcCtD
Bumetanide—Asthenia—Etoposide—sarcoma	0.00144	0.00256	CcSEcCtD
Bumetanide—Nausea—Mitoxantrone—sarcoma	0.00143	0.00255	CcSEcCtD
Bumetanide—Pruritus—Etoposide—sarcoma	0.00142	0.00253	CcSEcCtD
Bumetanide—Erythema multiforme—Doxorubicin—sarcoma	0.00138	0.00247	CcSEcCtD
Bumetanide—Diarrhoea—Etoposide—sarcoma	0.00137	0.00244	CcSEcCtD
Bumetanide—PTGS2—liver—sarcoma	0.00134	0.00305	CbGeAlD
Bumetanide—Dizziness—Etoposide—sarcoma	0.00133	0.00236	CcSEcCtD
Bumetanide—Muscle spasms—Epirubicin—sarcoma	0.00132	0.00236	CcSEcCtD
Bumetanide—Vomiting—Etoposide—sarcoma	0.00128	0.00227	CcSEcCtD
Bumetanide—Rash—Etoposide—sarcoma	0.00126	0.00225	CcSEcCtD
Bumetanide—Dermatitis—Etoposide—sarcoma	0.00126	0.00225	CcSEcCtD
Bumetanide—Headache—Etoposide—sarcoma	0.00126	0.00224	CcSEcCtD
Bumetanide—Vertigo—Epirubicin—sarcoma	0.00124	0.0022	CcSEcCtD
Bumetanide—Leukopenia—Epirubicin—sarcoma	0.00123	0.0022	CcSEcCtD
Bumetanide—Muscle spasms—Doxorubicin—sarcoma	0.00123	0.00218	CcSEcCtD
Bumetanide—Nausea—Etoposide—sarcoma	0.00119	0.00212	CcSEcCtD
Bumetanide—Arthralgia—Epirubicin—sarcoma	0.00117	0.00209	CcSEcCtD
Bumetanide—Chest pain—Epirubicin—sarcoma	0.00117	0.00209	CcSEcCtD
Bumetanide—Dry mouth—Epirubicin—sarcoma	0.00115	0.00204	CcSEcCtD
Bumetanide—Vertigo—Doxorubicin—sarcoma	0.00115	0.00204	CcSEcCtD
Bumetanide—Leukopenia—Doxorubicin—sarcoma	0.00114	0.00203	CcSEcCtD
Bumetanide—Thrombocytopenia—Epirubicin—sarcoma	0.0011	0.00196	CcSEcCtD
Bumetanide—Hyperhidrosis—Epirubicin—sarcoma	0.00109	0.00194	CcSEcCtD
Bumetanide—Chest pain—Doxorubicin—sarcoma	0.00109	0.00193	CcSEcCtD
Bumetanide—Arthralgia—Doxorubicin—sarcoma	0.00109	0.00193	CcSEcCtD
Bumetanide—Dry mouth—Doxorubicin—sarcoma	0.00106	0.00189	CcSEcCtD
Bumetanide—Hypotension—Epirubicin—sarcoma	0.00105	0.00187	CcSEcCtD
Bumetanide—PTGS2—lymph node—sarcoma	0.00102	0.00234	CbGeAlD
Bumetanide—Thrombocytopenia—Doxorubicin—sarcoma	0.00102	0.00181	CcSEcCtD
Bumetanide—Hyperhidrosis—Doxorubicin—sarcoma	0.00101	0.00179	CcSEcCtD
Bumetanide—Hypotension—Doxorubicin—sarcoma	0.000972	0.00173	CcSEcCtD
Bumetanide—Fatigue—Epirubicin—sarcoma	0.000969	0.00173	CcSEcCtD
Bumetanide—Gastrointestinal pain—Epirubicin—sarcoma	0.000919	0.00164	CcSEcCtD
Bumetanide—Fatigue—Doxorubicin—sarcoma	0.000897	0.0016	CcSEcCtD
Bumetanide—Urticaria—Epirubicin—sarcoma	0.000893	0.00159	CcSEcCtD
Bumetanide—Abdominal pain—Epirubicin—sarcoma	0.000889	0.00158	CcSEcCtD
Bumetanide—Gastrointestinal pain—Doxorubicin—sarcoma	0.000851	0.00151	CcSEcCtD
Bumetanide—Urticaria—Doxorubicin—sarcoma	0.000826	0.00147	CcSEcCtD
Bumetanide—Abdominal pain—Doxorubicin—sarcoma	0.000822	0.00146	CcSEcCtD
Bumetanide—Asthenia—Epirubicin—sarcoma	0.000807	0.00144	CcSEcCtD
Bumetanide—Pruritus—Epirubicin—sarcoma	0.000795	0.00142	CcSEcCtD
Bumetanide—Diarrhoea—Epirubicin—sarcoma	0.000769	0.00137	CcSEcCtD
Bumetanide—Asthenia—Doxorubicin—sarcoma	0.000746	0.00133	CcSEcCtD
Bumetanide—Dizziness—Epirubicin—sarcoma	0.000743	0.00132	CcSEcCtD
Bumetanide—Pruritus—Doxorubicin—sarcoma	0.000736	0.00131	CcSEcCtD
Bumetanide—Vomiting—Epirubicin—sarcoma	0.000715	0.00127	CcSEcCtD
Bumetanide—Diarrhoea—Doxorubicin—sarcoma	0.000712	0.00127	CcSEcCtD
Bumetanide—Rash—Epirubicin—sarcoma	0.000709	0.00126	CcSEcCtD
Bumetanide—Dermatitis—Epirubicin—sarcoma	0.000708	0.00126	CcSEcCtD
Bumetanide—Headache—Epirubicin—sarcoma	0.000704	0.00125	CcSEcCtD
Bumetanide—Dizziness—Doxorubicin—sarcoma	0.000688	0.00122	CcSEcCtD
Bumetanide—Nausea—Epirubicin—sarcoma	0.000668	0.00119	CcSEcCtD
Bumetanide—Vomiting—Doxorubicin—sarcoma	0.000661	0.00118	CcSEcCtD
Bumetanide—Rash—Doxorubicin—sarcoma	0.000656	0.00117	CcSEcCtD
Bumetanide—Dermatitis—Doxorubicin—sarcoma	0.000655	0.00117	CcSEcCtD
Bumetanide—Headache—Doxorubicin—sarcoma	0.000652	0.00116	CcSEcCtD
Bumetanide—Nausea—Doxorubicin—sarcoma	0.000618	0.0011	CcSEcCtD
